Peer Review History
| Original SubmissionJuly 10, 2019 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-19-19391 Implementation of a screening, brief intervention and referral to treatment programme for risky substance use in South African emergency centres: a mixed methods evaluation study PLOS ONE Dear Dr Claire van der Westhuizen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers note some important concerns that need to be addressed before your work can make a contribution to the field. Problems are noted regarding your theoretical and methodological approach, description of findings and discussion and conclusion. ================================= We would appreciate receiving your revised manuscript by Sep 27 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Cecilia Benoit Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study addresses a topic of high relevance to the field. Strengths include the focus on implementation and the LMIC setting. These are important gaps in the current literature. That said, there are some major limitations to this work that appear to restrict its potential contribution to the field. As it is currently written, the theoretical and methodological approach is not sufficiently justified or described, such that the work does not come across as intentional or structured. These limitations may or may not be able to be addressed at this point in time. A strengthened justification for why the study limitations are not fatal flaws is needed to establish the study’s contribution. 1. While I agree that the Introduction (or Methods section) should contain a description of this specific SBIRT programme and the implementation context and strategies, these could be summarized more briefly. More is needed in the Introduction on what is known about SBIRT (including an acknowledgement of the mixed clinical evidence, its role in the broader system/continuum of care, what is known about when and how it is effective) and why studies of implementation are important. The Introduction should clearly outline the rationale for the study and its contribution to the literature. Very little of the vast literature on SBIRT (in different settings/for different substances and levels of use) is cited. There is also no mention of implementation science or how it contributes to system enhancement. 2. The statement of study objectives at the end of the Introduction (lines 113-117) could be strengthened by listing the specific implementation factors and outcomes that were examined (this information is provided later on in the Methods section, but would be good to state up front to better frame the study). The objective(s) should follow from the Introduction and it should be clear how they answer the gap in existing research. 3. More detail is needed to explain how this is a mixed methods study (vs. a multiple methods study; line 119). Using the terminology of Creswell et al. would be helpful to show how the different study components fit together. 4. The study is described as being guided by the CFIR and Proctor’s taxonomy. It is not clearly argued why both are needed, how they fit together, what each brings that complements the other… A clearer framing of the theoretical underpinnings and mixed methods approach (see last comment) would greatly strengthen the front end of the Methods section. 5. Relatedly, a clearer distinction is needed between the constructs of feasibility and adoption. Could the count of patients screened not be considered an indicator of adoption? If possible, the number of patients who were eligible to be screened should be added (e.g., 13,136 patients out of how many were screened?). The meaning of the count of patients screened is hard to interpret in the absence of this information. In addition, if only 1 of 3 planned visits tended to take place, what does that say about feasibility? Finally, no information is provided on the referral to treatment component of SBIRT. This is a critical component of the SBIRT approach and an important aspect of feasibility/adoption. Were there treatment options for those who needed them? Were people referred and did they follow through? 6. Minor point – “game changer strategy” is inconsistently capitalized and written as one/two words (e.g., lines 75 and 142). 7. More information is needed on the sampling strategy for the qualitative component of the study. It looks like efforts were made to recruit stakeholders representing key groups across the system, however, this is not described explicitly. An overall summary of the stakeholder groups and their roles in the system would be helpful (e.g., policy makers, health planners/administrators, clinicians). This is needed to establish how the study answers to its objectives (e.g., who participated in the study and what were they able/not able to speak to?). Currently, the participants section (lines 140-148) is heavy on acronyms and assumes a level of familiarity with the South African system that most readers will not have. A more general statement of stakeholder roles would make this section more widely readable. Finally, is there a justification for the sample size, n=27? Was a sufficient number of people from each (broadly defined) stakeholder group to represent their perspectives? 8. It should be acknowledged as a limitation that patients were not included as participants. This is particularly the case since the Results section refers to “patients’ responses” to the programme and its effectiveness in fostering behavior change (paragraph starting line 208). This form of second-hand reporting (particularly from clinicians involved in delivering the programme) is not a strong approach to evaluating either patient perspectives or their behavior change outcomes. It may not be possible to address this limitation at this point. That said, given that the study is focused on implementation outcomes rather than programme effectiveness, I suggest deleting this paragraph and avoiding any comment on program effectiveness. In the absence of structured evaluation of programme mechanisms, including both positive and negative encounters, this finding is anecdotal. 9. More is needed to justify the claim that programme operations did not interfere with clinical care in the emergency setting (line 223). Was this reported by just one staff member? Did anyone report anything different? Was this explored in a structured fashion? 10. It is not clear what is meant by the quote pertaining to staff taking advantage and not doing what they are supposed to do (line 252). More information is needed on what this finding means and how it relates to issues of staff management (as indicated in line 250). 11. It is noted that there was a lack of compatibility between the SBIRT program and HAST services, and that this caused some difficulties in implementation (line 347). Some specific examples of these difficulties would be helpful here. 12. Many of the findings appear to identify barriers and problems in implementation, raising questions of the extent to which the programme was actually endorsed as appropriate. The authors suggest that those who were more removed from the programme held more negative views of its implementation and impact than those who were closer to the programme. Were the right people asked to report on implementation details? Did all participants know enough about the programme to be able to comment on the details, or are some of them simply echoing negative general perspectives of systems change and/or people who use drugs? Relatedly, the findings indicate a certain level of stigmatizing beliefs held by participants about people who use alcohol and other drugs – rather than stemming from a lack of programme familiarity/proximity per se, this speaks more generally to the negative views that many healthcare providers and administrators hold about problematic substance use. There is a broad literature on occurrence and impact of substance-related stigma in healthcare settings, including emergency room settings, which is relevant to interpreting this finding. As it stands, the relation of these stigmatizing beliefs to programme implementation specifically is not considered in the Results or Discussion sections. 13. There are points made in the Discussion that do not clearly follow from the material presented in the Results section. For example, it is noted that “Available financial and human resources, along with the top-down directive from the provincial government, were vital for programme implementation…” (lines 441-442). How was this assessed? The findings also appeared to identify problems with the top-down directives. Was a structured approach used to assess these features of implementation (e.g., were questions posed to stakeholders about the positive and negative role of these features of implementation and their impact)? Likewise, the Discussion refers to problems in connecting/engaging with middle management, yet this does not clearly follow from the results presented (lines 446-456). How was this evaluated? A thorough review of the Discussion is required to ensure that the interpretation follows from reported findings. 14. Clarification is required on what is meant by “evidence for task-sharing approaches”. Does this pertain to SBIRT interventions or is it about implementation processes more generally? What are the tasks being (or not being) shared? 15. The current Limitations section does not adequately address the limitations of this work and, importantly, how these are expected to affect the findings or what safeguards were used to minimize the impact of potential biases. Reviewer #2: The authors studied the feasibility and implementability of an SBIRT program in South African emergency rooms throw the examination of relevant outcomes during the first years of the program's implementation, such as screening rates, acceptability, and appropriateness. To do so, they use mainly qualitative but also some quantitative methods. Their results are similar to those encountered in SBIRT implementation studies elsewhere, with particularities relevant to the local context and eventually to other low-middle income contexts. The authors found high levels of stigma towards addiction, represented as a lack of confidence on the effectiveness of the brief interventions, especially among stakeholders not in the clinical sites. They also describe barriers regarding the health network and the clinical workflow. Overall, they found the SBIRT program to be highly implementable in their context, and give some recommendations on how to scale up the innovation. This study is methodologically sound and addresses one of the more challenging questions in the field of drugs and alcohol brief interventions: how to maximize their implementation to disseminate the strategy. I think it should be accepted with some minor issues that need to be addressed to improve its contextualization and clarity before publication: MINOR COMMENTS: Figures: Figures need to be reviewed and enetually re-made. The implementation process is well explained in figure 1, and the organizational context is depicted in the other figures, but there is some inconsistene and lack of important details: In Figures S1 and 2: it is not clear why different colors are used. For example, Do they represent hierarchical relationships? Also, the usage of colors does not look consistent between both figures. Figure 2 looks incomplete. I was expecting to see a summary of the main recommendations for each domain; instead, it only lists the CFIR constructs without any concrete example. Introduction: It is a good introduction, but more emphasis could be given to specific aspects of this research regarding the current literature. Other aspects need clarification: Lines 62 to 69: It is not clear in which aspects the authors expect the implementation to be different due to the socioeconomic background; or if there are clues about that in the new body of literature they mention. I would suggest further illustration. Line 71: it was difficult for me to follow what program were the authors referring throughout the text: Is the Teachable Moment program the same that was tested in the previous RCT? Is the intervention - training of the counselors implemented here the same that the one used on the RCT program? They mention the 'SBIRT program' or just 'the program' many times, also the 'Game Changer,' but is not clear what program they are referring. Lines 86 to 88: I understand that the intervention that showed the best effect in the previous RCT was a combined MI + Problem Solving. If that's the case, Why did this program delivered mostly an MI-based intervention? Did this contribute to the supposed lack of evidence ground of the initiative mentioned by some stakeholders? Methods: I think this section needs more precision in some critical aspects, particularly more clear operational definitions of the implementation outcomes for this study: Line 123: Please provide a summary of the CFIR constructs that were not used. Line 175: the word 'initial' is ambiguous here: does it refers to a general impression or to the idea they had before the program started? It seems to me that the construct of appropriateness was used to assess the suitability some of the innovation's parameters concerning the setting. If this is the case, I think the description given is not clear. Line 177: it is not clear for me that the Authors mean with 'the intention to try' Later in the paper, they elaborate on the readiness to adopt. Are these concepts equivalent? I would suggest a brief explanation and a more precise operational definition here. Results: This part is very clear and consistent in general. Line 187: Other than meeting criteria for risky substance use, what other requisites were needed to be eligible? Please be precise in the description of the inclusion criteria, because it impacts the overall impression on the program's feasibility the reader will have. Did the ASSIST specific scores define risky substance use? Line 191: Is it to say that 83% of risky substance users received the first intervention? Discussion: The discussion is very well supported by the results, and the paper concludes with recommendations to foster implementation in the future. I think some aspects could be better contextualized or explained to highlight the specific contribution of this research: Lines 380 to 382: how does this fact relate to local evidence (RCT mentioned in the beginning)? Lines: 416 to 417: the explanation offered about stake holder's view and how it differs from what's reported in the literature could be further elaborated: it looks like this finding is particularly specific to the context. Also, it is not clear in the last sentence, whether it was a mistake to interview 'distal' stakeholders. Finally, in the recommendations, authors should emphasize a differentiated strategy for early involvement of 'distal' stakeholders based on these findings. Data: I could not access the dataset; apparently, an application process is needed. I´m not sure whether this precludes from publication in this journal, or if the authors could explain if the dataset is not public for some reason. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Nicolas Barticevic Lantadilla [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Implementation of a screening, brief intervention and referral to treatment programme for risky substance use in South African emergency centres: a mixed methods evaluation study PONE-D-19-19391R1 Dear Dr. van der Westhuizen, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Cecilia Benoit Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors addressed all the concerns I had with the first version of this manuscript. This new version is much more precise and ready to be published. I have no further comments. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Nicolas Barticevic Lantadilla |
| Formally Accepted |
|
PONE-D-19-19391R1 Implementation of a screening, brief intervention and referral to treatment programme for risky substance use in South African emergency centres: a mixed methods evaluation study Dear Dr. van der Westhuizen: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Cecilia Benoit Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .